Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and combination therapy in liver cancer
Wei Ni(Tianjin Medical University Cancer Institute and Hospital), Ran Tian(Tianjin Medical University Cancer Institute and Hospital), Ruifang Niu(Tianjin Medical University Cancer Institute and Hospital), Zhaosong Wang(Tianjin Medical University Cancer Institute and Hospital), Hui Liu(Tianjin Medical University Cancer Institute and Hospital), Fei Zhang(Ministry of Education of the People's Republic of China), Li Liu(Nanyang Technological University), He Zhang(Obstetrics and Gynecology Hospital of Fudan University), Yanfen Cui(Tianjin Medical University Cancer Institute and Hospital), Mingzhu Zhang(Shandong Normal University), Wei Du(Zhejiang Chinese Medical University), Hui Guo(Qilu Hospital of Shandong University), Yueni Mo(Tianjin Medical University Cancer Institute and Hospital), Zhiyong Wang(Tianjin Medical University Cancer Institute and Hospital)
Cited by 7
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Functions of Shp2 in cancer
|Journal of Cellular and Molecular Medicine|2015|250